Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment. | Biomedicines | 2023 | 36830958 | PubTator, text mining | PubMed |
| Systematic Assessment of Protein C-Termini Mutated in Human Disorders. | Biomolecules | 2023 | 36830724 | PubTator, text mining | PubMed |
| Copper Exposure Induces Epithelial-Mesenchymal Transition-Related Fibrotic Change via Autophagy and Increase Risk of Lung Fibrosis in Human. | Antioxidants (Basel) | 2023 | 36830091 | PubTator, text mining | PubMed |
| A Comprehensive Review of Mammalian Pigmentation: Paving the Way for Innovative Hair Colour-Changing Cosmetics. | Biology (Basel) | 2023 | 36829566 | PubTator, text mining | PubMed |
| Copper homeostasis and the ubiquitin proteasome system. | Metallomics | 2023 | 36822629 | PubTator, text mining | PubMed |
| Cardiac copper content and its relationship with heart physiology: Insights based on quantitative genetic and functional analyses using BXD family mice. | Front Cardiovasc Med | 2023 | 36818345 | PubTator, text mining | PubMed |
| Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB. | Front Genet | 2023 | 36816017 | PubTator, text mining | PubMed |
| Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas. | Mediators Inflamm | 2023 | 36814682 | PubTator, text mining | PubMed |
| Emerging roles of m6A RNA modification in cancer therapeutic resistance. | Exp Hematol Oncol | 2023 | 36810281 | PubTator, text mining | PubMed |
| The factory, the antenna and the scaffold: the three-way interplay between the Golgi, cilium and extracellular matrix underlying tissue function. | Biol Open | 2023 | 36802341 | PubTator, text mining | PubMed |
| Reactive Cu2+-peptide intermediates revealed by kinetic studies gain relevance by matching time windows in copper metallomics. | Metallomics | 2023 | 36787891 | PubTator, text mining | PubMed |
| Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer's Disease: Experimental and Computational Insights. | ACS Omega | 2023 | 36777601 | PubTator, text mining | PubMed |
| Advances in reaction-based synthetic fluorescent probes for studying the role of zinc and copper ions in living systems. | J Clin Biochem Nutr | 2023 | 36777081 | PubTator, text mining | PubMed |
| COMMD proteins function and their regulating roles in tumors. | Front Oncol | 2023 | 36776284 | PubTator, text mining | PubMed |
| Caspase 3-specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress-induced apoptosis. | FEBS Open Bio | 2023 | 36776127 | PubTator, text mining | PubMed |
| Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes. | BMC Pulm Med | 2023 | 36774456 | PubTator, text mining | PubMed |
| Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. | Sci Rep | 2023 | 36774446 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC. | Sci Rep | 2023 | 36774418 | PubTator, text mining | PubMed |
| Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. | Cell Death Dis | 2023 | 36774340 | PubTator, text mining | PubMed |
| Silymarin Encapsulated Liposomal Formulation: An Effective Treatment Modality against Copper Toxicity Associated Liver Dysfunction and Neurobehavioral Abnormalities in Wistar Rats. | Molecules | 2023 | 36771180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=28